Progression-Free and Overall Survival of First-Line Treatments for Advanced Renal Cell Carcinoma: Indirect Comparison of Six Combination Regimens

SIMPLE SUMMARY: Recently, numerous treatments sharing similar mechanisms of action have been approved for advanced renal cell carcinoma. These combinations prolong survival compared to sunitinib, which was previously considered the standard of care in this context. Head-to-head comparisons between t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ossato, Andrea, Mengato, Daniele, Chiumente, Marco, Messori, Andrea, Damuzzo, Vera
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093553/
https://www.ncbi.nlm.nih.gov/pubmed/37046690
http://dx.doi.org/10.3390/cancers15072029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093553/
https://www.ncbi.nlm.nih.gov/pubmed/37046690
http://dx.doi.org/10.3390/cancers15072029

Ejemplares similares